扩张型心肌病高危一级亲属的筛查
本研究在25个中心对1365名扩张型心肌病患者的成年一级亲属进行超声心动图和心电图筛查,发现14.1%的一级亲属新诊断出扩张型心肌病、左室收缩功能障碍或左室扩大。新诊断比例在45-64岁人群、高血压和肥胖者中更高,但不同种族和性别间无统计学差异。结论支持对所有一级亲属进行临床筛查。
要点
- 约七分之一的一级亲属筛查出新发扩张型心肌病相关表现。
- 高血压和肥胖者筛查阳性率更高,但种族和性别间无差异。
- 先证者携带临床可报告变异时,一级亲属更易检出扩张型心肌病。
核心结论
- 在1365名一级亲属中,14.1%新诊断出扩张型心肌病、左室收缩功能障碍或左室扩大。
- 筛查阳性率在不同种族和性别间无统计学差异,支持对所有一级亲属筛查。
研究设计与样本
- 多中心研究,纳入25个中心的扩张型心肌病患者成年一级亲属,共1365名。
- 采用混合模型分析,考虑中心异质性和家族内相关性。
主要发现
- 新诊断扩张型心肌病占2.1%,左室收缩功能障碍占3.6%,左室扩大占8.4%。
- 45-64岁一级亲属新诊断比例高于18-44岁。
- 高血压和肥胖者年龄调整后筛查阳性率更高。
- 西班牙裔、非西班牙裔黑人和非西班牙裔白人的筛查阳性率分别为16.2%、15.2%和13.1%,无统计学差异。
- 女性14.6%与男性12.8%的筛查阳性率无统计学差异。
临床怎么用
- 应对扩张型心肌病患者的所有成年一级亲属进行超声心动图和心电图筛查。
- 筛查不应因种族或性别而有所选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cardiovascular screening is recommended for first-degree relatives (FDRs) of patients with dilated cardiomyopathy (DCM), but the yield of FDR screening is uncertain for DCM patients without known familial DCM, for non-White FDRs, or for DCM partial phenotypes of left ventricular enlargement (LVE) or left ventricular systolic dysfunction (LVSD). OBJECTIVES: This study examined the yield of clinical screening among reportedly unaffected FDRs of DCM patients. METHODS: Adult FDRs of DCM patients at 25 sites completed screening echocardiograms and ECGs. Mixed models accounting for site heterogeneity and intrafamilial correlation were used to compare screen-based percentages of DCM, LVSD, or LVE by FDR demographics, cardiovascular risk factors, and proband genetics results. RESULTS: A total of 1,365 FDRs were included, with a mean age of 44.8 ± 16.9 years, 27.5% non-Hispanic Black, 9.8% Hispanic, and 61.7% women. Among screened FDRs, 14.1% had new diagnoses of DCM (2.1%), LVSD (3.6%), or LVE (8.4%). The percentage of FDRs with new diagnoses was higher for those aged 45 to 64 years than 18 to 44 years. The age-adjusted percentage of any finding was higher among FDRs with hypertension and obesity but did not differ statistically by race and ethnicity (16.2% for Hispanic, 15.2% for non-Hispanic Black, and 13.1% for non-Hispanic White) or sex (14.6% for women and 12.8% for men). FDRs whose probands carried clinically reportable variants were more likely to be identified with DCM. CONCLUSIONS: Cardiovascular screening identified new DCM-related findings among 1 in 7 reportedly unaffected FDRs regardless of race and ethnicity, underscoring the value of clinical screening in all FDRs.
引用
- Ni H, Jordan E, Kinnamon DD, et al. Screening for Dilated Cardiomyopathy in At-Risk First-Degree Relatives. J Am Coll Cardiol. 2023. PMID: 37225358. doi:10.1016/j.jacc.2023.03.419
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。